CD3xCD20 Bispecific Antibodies Yields Long-Term Survival in Relapsed/Refractory B Cell Lymphoma: A Follow-up Study of Patients Treated in Pivotal Phase 1/2 Trials
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Blood |
| Volume | 142 |
| Issue number | Supplement 1 |
| Pages (from-to) | 618-618 |
| ISSN | 0006-4971 |
| DOIs | |
| Publication status | Published - 28 Nov 2023 |
ID: 386604961